NIRV — Nirvana Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Nirvana Life Sciences, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.

	2020 October 31st	2021 October 31st	2022 April 30th	2023 April 30th	2024 April 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.002	0.476	0.036	0.012	0.002
Net Total Receivables	0	0.009	0.014	0.017	0.019
Prepaid Expenses
Total Current Assets	0.002	0.532	0.144	0.069	0.021
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	0.343	0	—
Total Assets	0.002	0.532	0.487	0.069	0.021
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.532	0.549	0.648	1.01	1.16
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	0.532	0.549	0.649	1	1.15
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.529	-0.016	-0.162	-0.936	-1.13
Total Liabilities & Shareholders' Equity	0.002	0.532	0.487	0.069	0.021
Total Common Shares Outstanding